Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
47
FCN Quote, Financials, Valuation and Earnings
Last price:
$195.30
Seasonality move
:
9.03%
Day range:
$193.26 - $198.22
52-week range:
$185.93 - $243.60
Dividend yield:
0%
P/E ratio:
22.45x
P/S ratio:
1.88x
P/B ratio:
3.12x
Volume:
1.3M
Avg. volume:
244.4K
1-year change:
-1.39%
Market cap:
$7B
Revenue:
$3.5B
EPS (TTM):
$8.70
Earnings Data
Next earnings date for FCN
Feb 21
2025
Most recent earnings per share
$1.85
Missed by $0.21
(Oct 24/2024)
Consensus Estimate
$2.06
(Oct 24/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
FCN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/21/2025 | Q4 | $913.7M | -- | -- | $1.73 | -- |
| 10/24/2024 | Q3 | $946.2M | $926M | $1.85 | $2.06 | -$0.21 |
| 07/25/2024 | Q2 | $938.5M | $949.2M | $2.34 | $2.02 | $0.32 |
| 04/25/2024 | Q1 | $901.8M | $928.6M | $2.23 | $1.87 | $0.36 |
| 02/22/2024 | Q4 | $840.5M | $924.7M | $2.28 | $1.67 | $0.61 |
| 10/26/2023 | Q3 | -- | -- | $2.34 | $1.84 | $0.50 |
| 07/27/2023 | Q2 | -- | -- | $1.75 | $1.60 | $0.15 |
| 04/27/2023 | Q1 | -- | -- | $1.34 | $1.70 | -$0.36 |
| 02/23/2023 | Q4 | -- | -- | $1.33 | $1.35 | -$0.02 |
| 10/27/2022 | Q3 | -- | -- | $2.15 | $2.04 | $0.11 |
| 07/28/2022 | Q2 | -- | -- | $1.43 | $1.67 | -$0.24 |
| 04/28/2022 | Q1 | -- | -- | $1.66 | $1.44 | $0.22 |
| 02/24/2022 | Q4 | -- | -- | $1.07 | $1.16 | -$0.09 |
| 10/28/2021 | Q3 | -- | -- | $1.96 | $1.48 | $0.48 |
| 07/29/2021 | Q2 | -- | -- | $1.77 | $1.52 | $0.25 |
| 04/29/2021 | Q1 | -- | -- | $1.84 | $1.34 | $0.50 |
| 02/25/2021 | Q4 | -- | -- | $1.57 | $1.17 | $0.40 |
| 10/29/2020 | Q3 | -- | -- | $1.35 | $1.36 | -$0.01 |
| 07/30/2020 | Q2 | -- | -- | $1.27 | $1.04 | $0.23 |
| 04/30/2020 | Q1 | -- | -- | $1.49 | $1.54 | -$0.05 |
| 02/25/2020 | Q4 | -- | -- | $0.76 | $0.93 | -$0.17 |
| 10/24/2019 | Q3 | -- | -- | $1.59 | $0.92 | $0.67 |
| 07/25/2019 | Q2 | -- | -- | $1.73 | $0.97 | $0.76 |
| 04/25/2019 | Q1 | -- | -- | $1.63 | $0.99 | $0.64 |
| 02/26/2019 | Q4 | -- | -- | $0.83 | $0.54 | $0.29 |
| 10/25/2018 | Q3 | -- | -- | $1.00 | $0.58 | $0.42 |
| 07/26/2018 | Q2 | -- | -- | $1.14 | $0.63 | $0.51 |
| 04/26/2018 | Q1 | -- | -- | $1.04 | $0.62 | $0.42 |
| 02/22/2018 | Q4 | -- | -- | $0.78 | $0.50 | $0.28 |
| 10/26/2017 | Q3 | -- | -- | $0.83 | $0.59 | $0.24 |
| 07/27/2017 | Q2 | -- | -- | $0.40 | $0.52 | -$0.12 |
| 04/27/2017 | Q1 | -- | -- | -- | $0.60 | -- |
| 02/28/2017 | Q4 | -- | -- | $0.24 | $0.29 | -$0.05 |
| 10/27/2016 | Q3 | -- | -- | $0.52 | $0.50 | $0.02 |
| 07/28/2016 | Q2 | -- | -- | $0.66 | $0.60 | $0.06 |
| 04/28/2016 | Q1 | -- | -- | $0.83 | $0.37 | $0.46 |
| 02/25/2016 | Q4 | -- | -- | $0.24 | $0.27 | -$0.03 |
| 10/29/2015 | Q3 | -- | -- | $0.53 | $0.52 | $0.01 |
| 07/30/2015 | Q2 | -- | -- | $0.50 | $0.46 | $0.04 |
| 04/30/2015 | Q1 | -- | -- | $0.57 | $0.32 | $0.25 |
| 02/19/2015 | Q4 | -- | -- | $0.04 | $0.34 | -$0.30 |
FTI Consulting Earnings Questions
-
How Much did FTI Consulting Generate in Revenue Last Quarter?
FTI Consulting reported $926M worth of top line sales in its most recent quarter.
-
Did FTI Consulting Beat Earnings Last Quarter?
FTI Consulting announced earnings per share of $1.85 which represents a miss of analyst forecast a $2.06 per share.
-
Is FTI Consulting Profitable?
FTI Consulting reported $297.9M that represents $8.30 per share over the last quarter.
-
What is the Analyst Consensus for FTI Consulting EPS Next Year?
FTI Consulting's earnings are forecast to grow from $7.71 per share to $7.10 per share next year representing an increase of 5.88%.
-
When is FTI Consulting's Earnings Date?
FTI Consulting's next earnings date is February 21, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
